Johnson & Johnson Vaccine Is Safe and Effective, FDA Analysis Finds

Headline Roundup February 24th, 2021

The single-shot COVID-19 vaccine developed by Johnson & Johnson’s Janssen Biotech is safe and effective, according to an FDA briefing document released Wednesday. The news comes two days before a panel of outside advisers meets to determine whether to grant an Emergency Use Authorization (EUA) allowing distribution of the vaccine. Furthermore, the Biden Administration announced Wednesday it would distribute 3 to 4 million doses of J&J’s vaccine to states as early as next week. Johnson & Johnson is contracted to deliver 100 million doses to the U.S. by the end of June.

Left- and center-rated outlets featured the story more prominently than right-rated outlets. Coverage followed similar narratives across the spectrum, with most highlighting the vaccine's projected rate of effectiveness.

Johnson & Johnson Vaccine Is Safe and Effective, FDA Analysis Finds

From the Right
13320

The Food and Drug Administration backed Johnson & Johnson’s single-dose coronavirus vaccine as safe and effective on Wednesday as the agency weighs whether to clear the shot for emergency use.

FDA staff affirmed J&J’s finding that the vaccine was 66 percent effective overall at warding off moderate and severe COVID-19 cases and 85 percent effective at preventing the most serious infections.

While not as strong as Pfizer and Moderna’s two-dose vaccines, that efficacy rate could still make J&J’s shot a helpful weapon in the battle against the pandemic. It’s also...

Read full story
From the Center
13320

The Food and Drug Administration's staff released a briefing document on Wednesday endorsing Johnson & Johnson's one-shot coronavirus vaccine as safe and effective.

The latest: Assuming the FDA issues an emergency use authorization "without delay," meaning as soon as this weekend, White House coronavirus coordinator Jeff Zients said J&J will have 3 million to 4 million ready for distribution next week.

What's next: An FDA advisory panel will meet Friday to review the briefing document and vote on whether to recommend an emergency use authorization (EUA). The FDA will then...

Read full story
From the Left
13320

Documents released by the Food and Drug Administration on Wednesday indicate that Johnson & Johnson's Covid-19 vaccine is overall safe and highly effective — 86 percent — against the most severe outcomes of the illness.

The favorable review comes two days before a panel of independent advisers to the FDA is scheduled to discuss the company's application for emergency use. It is widely expected that the Vaccines and Related Biological Products Advisory Committee, or VRBPAC, will vote to recommend authorization of the vaccine.

Read full story

Try the New AllSides Mobile App

The only news app you’ll ever need. Now available on iOS and Android.